The IGF System and Aging
- PMID: 39418083
- PMCID: PMC11894535
- DOI: 10.1210/endrev/bnae029
The IGF System and Aging
Abstract
There is strong evidence that IGF signaling is involved in fundamental aspects of the aging process. However, the extracellular part of the IGF system is complex with various receptors, ligand effectors, high-affinity IGF-binding proteins, proteinases, and endogenous inhibitors that all, along with their biological context, must be considered. The IGF system components are evolutionarily conserved, underscoring the importance of understanding this system in physiology and pathophysiology. This review will briefly describe the different components of the IGF system and then discuss past and current literature regarding IGF and aging, with a focus on cellular senescence, model organisms of aging, centenarian genetics, and 3 age-related diseases-pulmonary fibrosis, Alzheimer disease, and macular degeneration-in appropriate murine models and in humans. Commonalities in mechanism suggest conditions where IGF system components may be disease drivers and potential targets in promoting healthy aging in humans.
Keywords: Alzheimer's disease; age-related macular degeneration; aging; insulin-like growth factors; pulmonary fibrosis.
© The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society.
References
-
- Bach LA. IGF-binding proteins. J Mol Endocrinol. 2018;61(1):T11‐T28. - PubMed
-
- Hakuno F, Takahashi SI. IGF1 receptor signaling pathways. J Mol Endocrinol. 2018;61(1):T69‐T86. - PubMed
-
- Conover CA, Oxvig C. The Pregnancy-Associated Plasma Protein-A (PAPP-A) story. Endocr Rev. 2023;44:1012‐1028. - PubMed
-
- Oxvig C, Conover CA. The stanniocalcin-PAPP-A-IGFBP-IGF axis. J Clin Endocrinol Metab. 2023;108:1624‐1633. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
